论文部分内容阅读
目的研究持续导管引流联合顺铂或博莱霉素心包灌注治疗肺癌性心包积液的临床效果。方法选择2014年1月至2016年3月安阳市人民医院收治的肺癌性心包积液患者80例。按照随机数字表法分为观察组与对照组,各40例。观察组给予持续导管引流+博莱霉素心包灌注治疗,对照组给予持续导管引流+顺铂心包灌注治疗;观察对比两组治疗效果及不良反应发生情况。结果药物灌注治疗后,观察组治疗有效率高于对照组,不良反应发生率低于对照组,差异有统计学意义(P<0.05)。结论持续导管引流联合博莱霉素比顺铂药物心包灌注治疗肺癌性心包积液临床效果显著,且不良反应小。
Objective To study the clinical effect of continuous catheter drainage combined with cisplatin or bleomycin pericardial infusion in the treatment of lung cancer pericardial effusion. Methods 80 patients with lung cancer pericardial effusion admitted to Anyang People’s Hospital from January 2014 to March 2016 were selected. According to random number table divided into observation group and control group, 40 cases each. The observation group was given continuous catheter drainage + bleomycin pericardial perfusion therapy, while the control group was given continuous catheter drainage + cisplatin pericardial perfusion therapy. The therapeutic effects and adverse reactions were observed and compared between the two groups. Results After drug infusion therapy, the effective rate of observation group was higher than that of control group, the incidence of adverse reactions was lower than that of control group, the difference was statistically significant (P <0.05). Conclusion Continuous catheter drainage combined with bleomycin than cisplatin drug pericardial perfusion therapy of lung cancer has a significant clinical effect, and adverse reactions.